EVELUATION OF PREOPERATIVE NASOPHARYNGEAL COLONISATION OF STAPHYLOCOCCUS AUREUS IN ORTHOPAEDIC IMPLANT SURGERY

EVELUATION OF PREOPERATIVE NASOPHARYNGEAL COLONISATION OF STAPHYLOCOCCUS AUREUS IN ORTHOPAEDIC IMPLANT SURGERY

Выбор валюты
Дата публикации статьи в журнале: 11.09.2019
Название журнала: Американский Научный Журнал, Выпуск: № (28) / 2019, Том: 2, Страницы в выпуске: 4-5
Автор:
Tbilisi, TSMU Microbiology Department, MD,PhD
Автор: George Obgaidze
Tbilisi, Head of Traumatology Department,TSMU The First University Clinic, MD,PhD
Автор: Inga gvasalia
Tbilisi, TSMU The First University Clinic, Physician of infectious diseases, MD,PhD
Анотация: Abstract. Staphylococcus aureus (S. aureus) is an independent risk factor for orthopaedic surgical site infection (SSI). There is a strong epidemiologic association between nasopharyngeal carriage of S. aureus and development of S. aureus SSIs. Carriers are two to nine times more likely to acquire S. aureus SSIs than noncarriers . Staphylococcus colonizing nasal or pharyngeal sites can become virulent and cause severe infections. In this study, We retrospectively studed both pharyngeal and nasal colonisation of St.aureus in 59 outpatients who visited TSMU the first university clinic traumatology department for screening purposes before orthopedic implant surgery. One swab was taken from the nostrils which was rotated gently in both nostrils, and one swab was taken from the pharynx by sweeping both tonsils. Specimens were inoculated onto manitol-salt and 5% sheep blood agar palate, which were incubated for 20 to 28 hours at 35°C to 37°C. After 24 hours negative plates were incubated for an additional 24 hours. The absolute S. aureus carriage was 25.42%, as 15 out of the 59 patients had S. aureus in the nose. 2 patients had SA both in the throat and nose. 1 patient had Candida albicans in the throat swab. Screening does not yielded positive nasal cultures MRSA . Thus, the nasal carrier rate was marginally significantly higher than that in the pharynx. We also eveluated antibiotic susceptibility test results which showed resistance to erythromycin, tetracycline,clindamycin and clarithromycine.
Ключевые слова: Staphylococcus aureus  antibiotics  screening  implant  surgery            
DOI:
Данные для цитирования: Tamar Didbaridze George Obgaidze Inga gvasalia. EVELUATION OF PREOPERATIVE NASOPHARYNGEAL COLONISATION OF STAPHYLOCOCCUS AUREUS IN ORTHOPAEDIC IMPLANT SURGERY. Американский Научный Журнал. Биологические науки. 11.09.2019; № (28) / 2019(2):4-5.

Список литературы: References: 1. Arciola CR, Cervellati M, Pirini V, Gamberini S, Montanaro L. Staphylococci in orthopaedic surgical wounds. New Microbiol. 2001;24:365–369 2. Calia FM, Wolinsky E, Mortimer EA Jr, Abrams JS, Rammelkamp CH Jr. Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis. J Hyg (Lond). 1969;67:49–57. 3. Weinstein HJ. The relation between the nasalstaphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med. 1959;260:1303–1308. [PubMed] 4. 24. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5–12:751–762. 5. Kluytmans J. Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus. J Hosp Infect. 1998;40(suppl B):S25–29. [ 6. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol. 2000;21:319–323. 7. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97–132; quiz 133–134; discussion 96. 8. Kenner J, O’Connor T, Piantanida N, Fishbain J, Eberly B, Viscount H, Uyehara C, Hospenthal D. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol. 2003;24:439–444 9. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39-7:971–979 10. Upton A, Lang S, Heffernan H. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother. 2003;51:613–617. doi: 10.1093/jac/dkg127. 1036–1043. doi: 10.1086/519929 11. Sandri AM, Dalarosa MG, de Ruschel Alcantara L, da Silva Elias L, Zavascki AP. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol. 2006;27:185– 187. doi: 10.1086/500625 12. Perl TM. Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. Surgery. 2003;134:S10–17. doi: 10.1016/S0039-6060(03)00391-X. 13. Konvalinka A, Errett L, Fong IW. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect. 2006;64:162–168. doi: 10.1016/j.jhin.2006.06.010. 14. Tong SY, Chen LF, Fowler VG., Jr Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: What is the clinical relevance? Semin Immunopathol. 2012;34:185–200. doi: 10.1007/s00281-011-0300-x.